Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients.
about
Yellow fever vaccine for patients with HIV infectionTravel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measuresCD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected PatientsExperimental therapies for yellow feverEfficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.Advances and controversies in yellow fever vaccinationLong-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.[Vaccinations and prophylaxis: what to consider].The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.Live viral vaccines in immunocompromised patients
P2860
Q24201042-6020CD25-1190-438F-99BC-29E75C34C422Q27687760-57B83937-DC75-468E-A494-9556738E6D05Q36219873-5EDEAB04-7F6B-431C-8654-8BF2A6CACE8AQ36586306-2D92CAC4-9224-436C-9DA2-5DAE6CE91D71Q37166091-601F8ABC-B170-45B7-8BEF-17715DDA2660Q37709619-1DB8EEAD-93DA-4327-96E8-FA605EDB8E1AQ38177767-BD4CEB34-C26F-40E8-982E-F692CC4EC096Q38638518-5CCC1EB7-ECA9-481E-BA4D-50B196F53316Q40241924-E7E5853C-A246-4D67-B74F-E0CE8E6BE8B9Q40252321-47F82DCC-F7A3-453B-BB1B-CE1F1C8B7B6CQ40560650-86A34B4E-EDF0-49E0-A352-5309CDE83D53Q40646400-7ED447D3-BE9D-4505-ACF1-21356E38B64CQ46239950-35A21EE0-8A9A-4DAF-8102-36F305DB6F68Q56765765-EC284813-3AC3-4883-8ED0-F4F02361AD6F
P2860
Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma HIV-RNA is the key dete ...... of 364 HIV-infected patients.
@en
type
label
Plasma HIV-RNA is the key dete ...... of 364 HIV-infected patients.
@en
prefLabel
Plasma HIV-RNA is the key dete ...... of 364 HIV-infected patients.
@en
P2093
P1476
Plasma HIV-RNA is the key dete ...... of 364 HIV-infected patients.
@en
P2093
Jean-Dominique Poveda
Jean-Louis Poirot
Jean-Luc Meynard
Jérôme Pacanowski
Karine Lacombe
Laurent Fonquernie
Magdalena Dabrowska
Pauline Campa
Pierre-Marie Girard
P304
P356
10.1097/QAI.0B013E318249DE59
P407
P577
2012-04-01T00:00:00Z